[1]
|
刘宗超, 李哲轩, 张阳, 周彤, 张婧莹, 游伟程, 潘凯枫, 李文庆. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-13.
|
[2]
|
Qiu, H., Cao, S. and Xu, R. (2021) Cancer Incidence, Mortality, and Burden in China: A Time-Trend Analysis and Comparison with the United States and United Kingdom Based on the Global Epidemiological Data Released in 2020. Cancer Communications, 41, 1037-1048. https://doi.org/10.1002/cac2.12197
|
[3]
|
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545.
https://doi.org/10.1016/S0140-6736(00)04046-0
|
[4]
|
Weichman, B.M. (2005) Inflammation: Basic Principles and Clinical Correlates. Agents and Actions, 25, 205-206.
|
[5]
|
Lira, S.A. and Furtado, G.C. (2012) The Biology of Chemokines and Their Receptors. Immunologic Research, 54, 111-120. https://doi.org/10.1007/s12026-012-8313-7
|
[6]
|
Homey, B., Müller, A. and Zlotnik, A. (2002) Chemokines: Agents for the Immunotherapy of Cancer? Nature Reviews Immunology, 2, 175-184. https://doi.org/10.1038/nri748
|
[7]
|
Kuper, H., Adami, H.‐O. and Trichopoulos, D. (2001) Infections as a Major Preventable Cause of Human Cancer. Journal of Internal Medicine, 249, 61-74. https://doi.org/10.1046/j.1365-2796.2001.00742.x
|
[8]
|
Wahl, L.M. and Kleinman, H.K. (1998) Tumor-Associated Macrophages as Targets for Cancer Therapy. Journal of the National Cancer Institute, 90, 1583-1584. https://doi.org/10.1093/jnci/90.21.1583
|
[9]
|
Brigati, C., Noonan, D.M., Albini, A. and Benelli, R. (2002) Tumors and Inflammatory Infiltrates: Friends or Foes? Clinical and Experimental Metastasis, 19, 358-258. https://doi.org/10.1023/A:1015587423262
|
[10]
|
Tsung, K., Dolan, J.P., Tsung, Y.L. and Norton, J.A. (2002) Macrophages as Effector Cells in Interleukin 12-Induced T Cell-Dependent Tumor Rejection. Cancer Research, 62, 5069-5075.
|
[11]
|
Schoppmann, S.F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K. and Kerjaschki, D. (2002) Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis. The American Journal of Pathology, 161, 947-956.
https://doi.org/10.1016/S0002-9440(10)64255-1
|
[12]
|
Chu, L.C., Goggins, M.G. and Fishman, E.K. (2017) Diagnosis and Detection of Pancreatic Cancer. The Cancer Journal, 23, 333-342. https://doi.org/10.1097/PPO.0000000000000290
|
[13]
|
邵全年, 周辉年, 李向阳, 肖竞英, 焦作义. 基于术前系统免疫炎症指数及控制营养状况评分对胰腺癌根治术后列线图预后预测模型的构建及评价[J/OL]. 中国普外基础与临床杂志, 2021: 1-7[2021-10-09].
http://kns.cnki.net/kcms/detail/51.1505.R.20210818.1107.002.html
|
[14]
|
Shui, Y., Li, M., Su, J., Chen, M., Gu, X. and Guo, W. (2021) Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Pancreatic Cancer: A Meta-Analysis of 2,365 Patients. Aging, 13, 20585-20597.
https://doi.org/10.18632/aging.203449
|
[15]
|
Kim, J.S. and Kang, C.M. (2021) A Systemic Inflammation Response Index (SIRI) Correlates with Survival and Predicts Oncological Outcome in Resected Pancreatic Cancer Following Neo-Adjuvant Chemotherapy. Annals of Hepato-Biliary-Pancreatic Surgery, 25, Article No. S358. https://doi.org/10.14701/ahbps.EP-159
|
[16]
|
Masateru, Y., Tsuyoshi, K., Shintaro, K., Michinori, H., Sho, O., Naruhiko, H., Megumi, Y. and Hideki, O. (2019) Verification of Inflammation-Based Prognostic Marker as a Prognostic Indicator in Hepatocellular Carcinoma. Annals of Gastroenterological Surgery, 3, 667-675. https://doi.org/10.1002/ags3.12286
|
[17]
|
南月敏, 高沿航, 王荣琦, 李文刚, 赵素贤, 杨明. 原发性肝癌二级预防共识(2021年版) [J]. 实用肝脏病杂志, 2021, 24(2): 305-318.
|
[18]
|
张劲夫, 范正军, 梁润威, 孙涛, 乔兵兵. 术前SIRI和PLR对肝癌切除术后病人生存预测价值分析[J]. 中国实用外科杂志, 2018, 38(2): 210-218.
|
[19]
|
Atsushi, S., Yukio, I., Kohei, S., Toshifuni, M., Masayuki, O. and Seigo, K. (2006) Prognostic Value of Preoperative Peripheral Blood Monocyte Count in Patients with Hepatocellular Carcinoma. Surgery, 139, 755-764.
https://doi.org/10.1016/j.surg.2005.10.009
|
[20]
|
Xiao, G.-Q., Liu, C., Liu, D.-L., Yang, J.-Y. and Yan, L.-N. (2013) Neutrophil-Lymphocyte Ratio Predicts the Prognosis of Patients with Hepatocellular Carcinoma after Liver Transplantation. World Journal of Gastroenterology, 19, 8398-8407. https://doi.org/10.3748/wjg.v19.i45.8398
|
[21]
|
Farhood, B., Najafi, M. and Mortezaee, K. (2019) CD8+ Cytotoxic T Lymphocytes in Cancer Immunotherapy: A Review. Journal of Cellular Physiology, 234, 8509-8521. https://doi.org/10.1002/jcp.27782
|
[22]
|
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386. https://doi.org/10.1002/ijc.29210
|
[23]
|
Fock, K.M. (2014) Review Article: The Epidemiology and Prevention of Gastric Cancer. Alimentary Pharmacology & Therapeutics, 40, 250-260. https://doi.org/10.1111/apt.12814
|
[24]
|
Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X.Q. and He, J. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[25]
|
Siegel Rebecca, L., Miller Kimberly, D. and Jemal, A. (2016) Cancer Statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 7-30. https://doi.org/10.3322/caac.21332
|
[26]
|
Shi, H., Jiang, Y., Cao, H., Zhu, H., Chen, B., Ji, W. and Nicolazzo, C. (2018) Nomogram Based on Systemic Immune-Inflammation Index to Predict Overall Survival in Gastric Cancer Patients. Disease Markers, 2018, Article ID: 1787424. https://doi.org/10.1155/2018/1787424
|
[27]
|
Yang, H., Wei, B. and Hu, B. (2021) Chronic Inflammation and Long-Lasting Changes in the Gastric Mucosa after Helicobacter pylori Infection Involved in Gastric Cancer. Inflammation Research.
https://doi.org/10.1007/s00011-021-01501-x
|
[28]
|
丁平安, 杨沛刚, 张志栋, 田园, 王冬, 赵雪峰, 檀碧波, 刘羽, 李勇, 赵群. 系统性免疫炎症指数与胃癌根治术后患者预后的相关性研究[J]. 中华消化杂志, 2021, 41(8): 534-540.
|
[29]
|
Folkman, J. (2007) Angiogenesis: An Organizing Principle for Drug Discovery? Nature Reviews Drug Discovery, 6, 273-286. https://doi.org/10.1038/nrd2115
|
[30]
|
Rachidi, S., Metelli, A., Riesenberg, B., Wu, B.X., Nelson, M.H., Wallace, C., et al. (2017) Platelets Subvert T Cell Immunity against Cancer via GARP-TGFβ Axis. Science Immunology, 2, Article No. eaai7911.
https://doi.org/10.1126/sciimmunol.aai7911
|
[31]
|
Zhang, K., Ping, L., Ou, X., Bazhabayi, M. and Xiao, X. (2021) A Systemic Inflammation Response Score for Prognostic Prediction of Breast Cancer Patients Undergoing Surgery. Journal of Personalized Medicine, 11, Article No. 413. https://doi.org/10.3390/jpm11050413
|
[32]
|
Danforth David, N. (2021) The Role of Chronic Inflammation in the Development of Breast Cancer. Cancers, 13, Article No. 3918. https://doi.org/10.3390/cancers13153918
|
[33]
|
Chang, S.-L., André, T., Francine, D., Caroline, D. and Nunzio, V. (2021) Associations of Biomarkers of Inflammation and Breast Cancer in the Breast Adipose Tissue of Women with Combined Measures of Adiposity. Journal of Obesity, 2021, Article ID: 3620147. https://doi.org/10.1155/2021/3620147
|
[34]
|
Göbel, A., Dell’Endice, S., Jaschke, N., Pählig, S., Shahid, A., Hofbauer Lorenz, C. and Rachner Tilman, D. (2021) The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone. International Journal of Molecular Sciences, 22, Article No. 5078. https://doi.org/10.3390/ijms22105078
|
[35]
|
庞健, 王守满, 廖立秋, 刘祥彦. 全身免疫炎症指数与三阴性乳腺癌新辅助化疗疗效及预后的相关性[J/OL]. 中南大学学报(医学版), 2021: 1-8[2021-10-10]. http://kns.cnki.net/kcms/detail/43.1427.R.20210927.1707.002.html
|
[36]
|
Liu, Q., Tan, Q., Zheng, Y., Chen, K., Qian, C., Li, N., Wang, Q. and Cao, X. (2021) Withdrawal: Blockade of Fas Signaling in Breast Cancer Cells Suppresses Tumor Growth and Metastasis via Disruption of Fas Signaling-Initiated Cancer-Related Inflammation. The Journal of Biological Chemistry, 296, Article No. 100757.
https://doi.org/10.1016/j.jbc.2021.100757
|